• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乙型肝炎病毒相关肝癌中高度突变基因的综合分析

Integrative analysis of highly mutated genes in hepatitis B virus-related hepatic carcinoma.

作者信息

Kong Fanyun, Kong Delong, Yang Xiaoying, Yuan Dongchen, Zhang Ning, Hua Xuan, You Hongjuan, Zheng Kuiyang, Tang Renxian

机构信息

Jiangsu Key Laboratory of Immunity and Metabolism, Department of Pathogenic Biology and Immunology, Xuzhou Medical University, Xuzhou, Jiangsu, P. R. China.

National Demonstration Center for Experimental Basic Medical Sciences Education, Xuzhou Medical University, Xuzhou, Jiangsu, P. R. China.

出版信息

Cancer Med. 2020 Apr;9(7):2462-2479. doi: 10.1002/cam4.2903. Epub 2020 Feb 4.

DOI:10.1002/cam4.2903
PMID:32017470
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7131865/
Abstract

Gene mutation is responsible for the development of hepatocellular carcinoma (HCC) with hepatitis B virus (HBV) infection; however, the characteristics and associated biological functions of highly mutated genes, in which the mutation frequencies are at least 5% in HCC patients with HBV infection, are not clearly evaluated. In the study, we analyzed the information regarding somatic mutation obtained by whole-exome sequencing in 280 HBV-related HCC tissues from public databases and published studies. Via integrative analysis, 78 genes, including TP53, TTN, MUC16, CTNNB1, and PCLO were summarized as highly mutated genes, and some of these mutated genes were further identified as cancer driver genes. Besides, we discovered that the highly mutated genes were enriched with various biological functions and pathways. The expression of many of highly mutated genes was found to be significantly altered in HBV-related HCC, and several highly mutated genes were related to a variety of clinical factors and associated with the poor survival of the disease. Taken together, these results could enrich our understanding of highly mutated genes and their relationships with HBV-related HCC. Some of the identified highly mutated genes might be used as novel biomarkers of disease prognosis, or as molecular targets for the treatment of HCC with HBV infection.

摘要

基因突变是导致乙型肝炎病毒(HBV)感染相关肝细胞癌(HCC)发生的原因;然而,在HBV感染的HCC患者中,突变频率至少为5%的高突变基因的特征及相关生物学功能尚未得到明确评估。在本研究中,我们分析了来自公共数据库和已发表研究的280例HBV相关HCC组织全外显子测序获得的体细胞突变信息。通过综合分析,包括TP53、TTN、MUC16、CTNNB1和PCLO在内的78个基因被总结为高突变基因,其中一些突变基因进一步被鉴定为癌症驱动基因。此外,我们发现高突变基因富集了多种生物学功能和信号通路。许多高突变基因的表达在HBV相关HCC中显著改变,并且几个高突变基因与多种临床因素相关,且与疾病的不良预后有关。综上所述,这些结果可以丰富我们对高突变基因及其与HBV相关HCC关系的理解。一些已鉴定的高突变基因可能用作疾病预后的新型生物标志物,或作为HBV感染相关HCC治疗的分子靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da75/7131865/22be1ae5d92a/CAM4-9-2462-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da75/7131865/a82c86d1c1a1/CAM4-9-2462-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da75/7131865/25dd30a2e57d/CAM4-9-2462-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da75/7131865/b7bb8964d49a/CAM4-9-2462-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da75/7131865/cdccbae975a3/CAM4-9-2462-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da75/7131865/bb50ec0416f3/CAM4-9-2462-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da75/7131865/1d277717e2ae/CAM4-9-2462-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da75/7131865/22be1ae5d92a/CAM4-9-2462-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da75/7131865/a82c86d1c1a1/CAM4-9-2462-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da75/7131865/25dd30a2e57d/CAM4-9-2462-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da75/7131865/b7bb8964d49a/CAM4-9-2462-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da75/7131865/cdccbae975a3/CAM4-9-2462-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da75/7131865/bb50ec0416f3/CAM4-9-2462-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da75/7131865/1d277717e2ae/CAM4-9-2462-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da75/7131865/22be1ae5d92a/CAM4-9-2462-g007.jpg

相似文献

1
Integrative analysis of highly mutated genes in hepatitis B virus-related hepatic carcinoma.乙型肝炎病毒相关肝癌中高度突变基因的综合分析
Cancer Med. 2020 Apr;9(7):2462-2479. doi: 10.1002/cam4.2903. Epub 2020 Feb 4.
2
Knowledge-based analyses reveal new candidate genes associated with risk of hepatitis B virus related hepatocellular carcinoma.基于知识的分析揭示了与乙型肝炎病毒相关肝细胞癌风险相关的新候选基因。
BMC Cancer. 2020 May 11;20(1):403. doi: 10.1186/s12885-020-06842-0.
3
Identification of Potential Key Genes for Hepatitis B Virus-Associated Hepatocellular Carcinoma by Bioinformatics Analysis.
J Comput Biol. 2019 May;26(5):485-494. doi: 10.1089/cmb.2018.0244. Epub 2019 Mar 12.
4
Comprehensive analyses of mutations and hepatitis B virus integration in hepatocellular carcinoma with clinicopathological features.肝细胞癌中具有临床病理特征的突变和乙型肝炎病毒整合的综合分析。
J Gastroenterol. 2016 May;51(5):473-86. doi: 10.1007/s00535-015-1126-4. Epub 2015 Nov 9.
5
Hepatitis B-related hepatocellular carcinoma: classification and prognostic model based on programmed cell death genes.乙型肝炎相关肝细胞癌:基于程序性细胞死亡基因的分类和预后模型。
Front Immunol. 2024 May 10;15:1411161. doi: 10.3389/fimmu.2024.1411161. eCollection 2024.
6
The expression of long non coding RNA genes is associated with expression with polymorphisms of HULC rs7763881 and MALAT1 rs619586 in hepatocellular carcinoma and HBV Egyptian patients.长链非编码 RNA 基因的表达与肝癌和 HBV 埃及患者中 HULC rs7763881 和 MALAT1 rs619586 多态性的表达相关。
J Cell Biochem. 2019 Sep;120(9):14645-14656. doi: 10.1002/jcb.28726. Epub 2019 Apr 22.
7
Nonreceptor protein tyrosine phosphatases (NRPTPs) gene family associates with the risk of hepatocellular carcinoma in a Chinese hepatitis B virus-related subjects.非受体蛋白酪氨酸磷酸酶(NRPTPs)基因家族与中国乙型肝炎病毒相关人群的肝细胞癌风险相关。
Mol Carcinog. 2020 Aug;59(8):980-988. doi: 10.1002/mc.23228. Epub 2020 Jun 2.
8
Hypermethylation of GNA14 and its tumor-suppressive role in hepatitis B virus-related hepatocellular carcinoma.GNA14 的高甲基化及其在乙型肝炎病毒相关肝细胞癌中的肿瘤抑制作用。
Theranostics. 2021 Jan 1;11(5):2318-2333. doi: 10.7150/thno.48739. eCollection 2021.
9
Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.鉴定参与 HBV 相关 HCC 发病机制的潜在 miRNA-mRNA 调控网络。
J Transl Med. 2019 Jan 3;17(1):7. doi: 10.1186/s12967-018-1761-7.
10
Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.乙型肝炎病毒相关肝细胞癌中异常Wnt信号通路的综合分析
World J Gastroenterol. 2015 May 28;21(20):6317-28. doi: 10.3748/wjg.v21.i20.6317.

引用本文的文献

1
Splicing factor PTBP1 promotes hepatocarcinogenesis via oncogenic splice-switching of MAPT.剪接因子PTBP1通过MAPT的致癌性剪接转换促进肝癌发生。
Oncol Res. 2025 Apr 18;33(5):1121-1133. doi: 10.32604/or.2025.060958. eCollection 2025.
2
Prognostic modeling of hepatocellular carcinoma based on T-cell proliferation regulators: a bioinformatics approach.基于 T 细胞增殖调节剂的肝细胞癌预后建模:一种生物信息学方法。
Front Immunol. 2024 Oct 9;15:1444091. doi: 10.3389/fimmu.2024.1444091. eCollection 2024.
3
A pyroptosis-related lncRNA-based prognostic index for hepatocellular carcinoma by relative expression orderings.

本文引用的文献

1
Contribution of Hepatitis B Virus Infection to the Aggressiveness of Primary Liver Cancer: A Clinical Epidemiological Study in Eastern China.乙型肝炎病毒感染对原发性肝癌侵袭性的影响:中国东部地区的一项临床流行病学研究
Front Oncol. 2019 May 21;9:370. doi: 10.3389/fonc.2019.00370. eCollection 2019.
2
NCKAP1 improves patient outcome and inhibits cell growth by enhancing Rb1/p53 activation in hepatocellular carcinoma.NCKAP1 通过增强 Rb1/p53 激活改善肝癌患者预后并抑制细胞生长。
Cell Death Dis. 2019 May 8;10(5):369. doi: 10.1038/s41419-019-1603-4.
3
Promotion of growth factor signaling as a critical function of β-catenin during HCC progression.
一种基于细胞焦亡相关长链非编码RNA的肝细胞癌预后指数,通过相对表达排序得出。
Transl Cancer Res. 2024 Mar 31;13(3):1406-1424. doi: 10.21037/tcr-23-1804. Epub 2024 Mar 25.
4
ARID1A deficiency promotes progression and potentiates therapeutic antitumour immunity in hepatitis B virus-related hepatocellular carcinoma.ARID1A 缺失促进乙型肝炎病毒相关肝细胞癌的进展并增强抗肿瘤免疫治疗。
BMC Gastroenterol. 2024 Jan 2;24(1):11. doi: 10.1186/s12876-023-03059-w.
5
Uncovering the Gut-Liver Axis Biomarkers for Predicting Metabolic Burden in Mice.揭示肠道-肝脏轴生物标志物,以预测小鼠的代谢负担。
Nutrients. 2023 Jul 31;15(15):3406. doi: 10.3390/nu15153406.
6
Comprehensive analysis of FOXM1 immune infiltrates, m6a, glycolysis and ceRNA network in human hepatocellular carcinoma.全面分析人肝癌中 FOXM1 免疫浸润、m6A、糖酵解和 ceRNA 网络。
Front Immunol. 2023 May 10;14:1138524. doi: 10.3389/fimmu.2023.1138524. eCollection 2023.
7
A lipid metabolism-based prognostic risk model for HBV-related hepatocellular carcinoma.基于脂质代谢的乙型肝炎病毒相关性肝细胞癌预后风险模型。
Lipids Health Dis. 2023 Apr 1;22(1):46. doi: 10.1186/s12944-023-01780-9.
8
Machine learning integrations develop an antigen-presenting-cells and T-Cells-Infiltration derived LncRNA signature for improving clinical outcomes in hepatocellular carcinoma.机器学习整合开发了一种由抗原呈递细胞和 T 细胞浸润衍生的 LncRNA 特征,以改善肝细胞癌的临床结局。
BMC Cancer. 2023 Mar 28;23(1):284. doi: 10.1186/s12885-023-10766-w.
9
The somatic mutational landscape and role of the ARID1A gene in hepatocellular carcinoma.ARID1A基因在肝细胞癌中的体细胞突变图谱及作用
Heliyon. 2023 Mar 8;9(3):e14307. doi: 10.1016/j.heliyon.2023.e14307. eCollection 2023 Mar.
10
Network analysis of hepatocellular carcinoma liquid biopsies augmented by single-cell sequencing data.通过单细胞测序数据增强的肝细胞癌液体活检的网络分析
Front Genet. 2022 Aug 25;13:921195. doi: 10.3389/fgene.2022.921195. eCollection 2022.
促进生长因子信号转导是 β-catenin 在 HCC 进展过程中的关键功能。
Nat Commun. 2019 Apr 23;10(1):1909. doi: 10.1038/s41467-019-09780-z.
4
Overexpression of RNF38 facilitates TGF-β signaling by Ubiquitinating and degrading AHNAK in hepatocellular carcinoma.RNF38 的过表达通过泛素化和降解肝细胞癌中的 AHNAK 来促进 TGF-β 信号通路。
J Exp Clin Cancer Res. 2019 Mar 5;38(1):113. doi: 10.1186/s13046-019-1113-3.
5
Somatic mutations of PREX2 gene in patients with hepatocellular carcinoma.肝细胞癌患者 PREX2 基因的体细胞突变。
Sci Rep. 2019 Feb 22;9(1):2552. doi: 10.1038/s41598-018-36810-5.
6
Molecular mechanistic insight of hepatitis B virus mediated hepatocellular carcinoma.乙型肝炎病毒导致肝细胞癌的分子机制见解。
Microb Pathog. 2019 Mar;128:184-194. doi: 10.1016/j.micpath.2019.01.004. Epub 2019 Jan 3.
7
Identification of genes involved in the regulation of TERT in hepatocellular carcinoma.鉴定参与调控肝细胞癌 TERT 的基因。
Cancer Sci. 2019 Feb;110(2):550-560. doi: 10.1111/cas.13884. Epub 2019 Jan 4.
8
Comparing self-directed methods for training staff to create graphs using Graphpad Prism.比较使用 Graphpad Prism 创建图形的员工自我指导方法。
J Appl Behav Anal. 2019 Feb;52(1):188-204. doi: 10.1002/jaba.522. Epub 2018 Nov 1.
9
Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next-Generation Sequencing for Matching Patients to Targeted and Immune Therapies.肝细胞癌的前瞻性基因分型:下一代测序在将患者与靶向和免疫治疗相匹配方面的临床意义。
Clin Cancer Res. 2019 Apr 1;25(7):2116-2126. doi: 10.1158/1078-0432.CCR-18-2293. Epub 2018 Oct 29.
10
Somatic mutation profiling of liver and biliary cancer by targeted next generation sequencing.通过靶向新一代测序对肝癌和胆管癌进行体细胞突变分析
Oncol Lett. 2018 Nov;16(5):6003-6012. doi: 10.3892/ol.2018.9371. Epub 2018 Aug 29.